NCT00467740 - Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma | Biotech Hunter

Enrollment

296

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2008

Conditions

Asthma

Interventions

DRUG

BI 1744 CL

Trial Locations (37)

Unknown

1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood, Lakewood

1222.6.062 Boehringer Ingelheim Investigational Site, Los Angeles

1222.6.066 Allergy & Asthma Medical Group and Rsrch Ctr, APC, San Diego

1222.6.069 Allergy Associates Medical Group, San Diego

1222.6.068 National Jewish Medical Center, Denver

1222.6.073 Boehringer Ingelheim Investigational Site, Wheat Ridge

1222.6.067 Northeast Medical Research Associates, Inc, North Darthmouth

1222.6.061 Center for Human Genomics, Winston-Salem

1222.6.072 Boehringer Ingelheim Investigational Site, Kileen

1222.6.071 Pulmonary Consultants, Tacoma

1222.6.017 Boehringer Ingelheim Investigational Site, Calgary

1222.6.006 Boehringer Ingelheim Investigational Site, Vancouver

1222.6.012 Boehringer Ingelheim Investigational Site, Winnipeg

1222.6.016 Boehringer Ingelheim Investigational Site, Winnipeg

1222.6.011 Boehringer Ingelheim Investigational Site, Hamilton

1222.6.003 Boehringer Ingelheim Investigational Site, Mississauga

1222.6.013 Boehringer Ingelheim Investigational Site, Ottawa

1222.6.005 Boehringer Ingelheim Investigational Site, Toronto

1222.6.009 Boehringer Ingelheim Investigational Site, Toronto

1222.6.008 Boehringer Ingelheim Investigational Site, Montreal

1222.6.015 Boehringer Ingelheim Investigational Site, Montreal

1222.6.007 Boehringer Ingelheim Investigational Site, Sherbrooke

1222.6.002 Boehringer Ingelheim Investigational Site, Ste-Foy

1222.6.004 Boehringer Ingelheim Investigational Site, Saskatoon

1222.6.3303A Boehringer Ingelheim Investigational Site, Béthune

1222.6.3308A Boehringer Ingelheim Investigational Site, Briançon

1222.6.3302A Boehringer Ingelheim Investigational Site, Grenoble

1222.6.3306A Boehringer Ingelheim Investigational Site, Lille

1222.6.3301A Boehringer Ingelheim Investigational Site, Montpellier

1222.6.3304A Boehringer Ingelheim Investigational Site, Nîmes

1222.6.3305A Boehringer Ingelheim Investigational Site, Saint-Pierre Cedex - La Réunion

1222.6.031 Boehringer Ingelheim Investigational Site, Berlin

1222.6.034 Boehringer Ingelheim Investigational Site, Berlin

1222.6.037 Boehringer Ingelheim Investigational Site, Gauting

1222.6.038 Boehringer Ingelheim Investigational Site, Hamburg

1222.6.032 Boehringer Ingelheim Investigational Site, Rüdersdorf

1222.6.036 Boehringer Ingelheim Investigational Site, Wiesloch